Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-20

Clinical Trial Update: Ropivacaine Concentration and Rebound Pain [Phase 4]

View source ↗

Summary

Phase 4 trial assessing ropivacaine concentration and rebound pain after distal radius fracture treatment has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ropivacaine (Ropivacaine)

Snippet

Sponsor: Oslo University Hospital | Conditions: Radius Fracture Distal, Rebound Pain | Phase 4 | Status: COMPLETED